EUVIMED · CrossrefJournal
Blood Vessels, Thrombosis & Hemostasis
ISSN 2950-3272 · Elsevier BV
Latest articles
Platelets mediate fibrin-induced thromboinflammation and NETosis through a GPVI-polyphosphate-FXIIa procoagulant axis
Decoding full-length factor VIII through the structural and functional lens of its B domain
Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A
Clinical significance of annexin A2 heterotetramer in sepsis
Disease-specific safety and efficacy of DOACs vs LMWH for CAT in patients with brain metastases: a real-world analysis
Thromborepair: the tissue repair partner to thromboinflammation
Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A
An iPSC model of thrombocytopenia-absent radius syndrome links aberrant splicing to impaired megakaryopoiesis
An international collaboration to characterize thrombotic events in TEMPI syndrome
Seconds-resolved in vivo measurements reveal rapid, serotonin transporter–independent plasma serotonin clearance
Interindividual variability in platelet aggregation among aspirin-treated patients: a large retrospective analysis
Beyond thrombosis: a scoping review of patient-reported outcomes in antiphospholipid syndrome
The role of anti–factor Xa in patients with cancer receiving prophylactic low-molecular-weight heparin: a meta-analysis
Real-world thrombotic and survival outcomes with ESAs in cancer-related anemia
Thromboembolic and hemorrhagic risks after mastectomy with vs without direct-to-implant reconstruction
Endothelial indoleamine 2,3-dioxygenase 1 drives high-tryptophan diet–mediated thrombosis in cancer-bearing mice
Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases
Becerra M, Soogoor N, Vu J, Wortley J, Sathyamoorthy M. A contemporary review of plasminogen activator inhibitor 1 in cardiovascular disease and broader disease state implications. Blood Vessel Thromb Hemost. 2026;3(2):100141.
Antineoplastic therapies associated with venous thromboembolism: disproportionality analysis of the WHO database
Rial C, Gendron N, Le Beller C, et al. Evaluation of an IgG anti-PF4/H chemiluminescent immunoassay in the diagnosis of heparin-induced thrombocytopenia. Blood Vessel Thromb Hemost. 2025;2(4):100084.
Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
The 2025 McMaster Immune Thrombocytopenia (ITP) Summit: insights from autoimmune hemolytic anemia
Low platelets, high stakes: pregnancy after a diagnosis of immune thrombocytopenia
Targeting plasma cells for treatment of immune thrombocytopenia
The molecular pathophysiology of immune thrombocytopenia: the new frontier
Clinical and economic impact of rFVIIa prophylaxis in Glanzmann thrombasthenia: cohort analysis in Saudi Arabia
In memoriam: Douglas B. Cines (8 November 1947-7 December 2025)
The platelet variability index as a diagnostic tool in immune thrombocytopenia: a cohort study from Mexico
Thromboinflammation and immunothrombosis drive lung pathology after bacterial and viral infection
Bruton’s tyrosine kinase inhibitors in primary immune thrombocytopenia: pathophysiology and clinical evidence
EUVIMED